Royal Bank Of Canada Orchard Therapeutics PLC Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.45 - $0.69 $900 - $1,380	-2,000 Reduced 99.55%	9 $0
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.78 $840 - $1,560	2,000 Added 22222.22%	2,009 $1,000
Q1 2022 May 16, 2022	BUY	$0.7 - $1.51 $0 - $1	1 Added 12.5%	9 $0
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $12,518 - $24,066	-10,792 Reduced 99.93%	8 $0
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $1,792 - $3,432	800 Added 8.0%	10,800 $25,000
Q2 2021 Aug 16, 2021	BUY	$4.39 - $7.23 $43,900 - $72,300	10,000 New	10,000 $44,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.